Literature DB >> 20732331

Diversity of bisubstrate binding modes of adenosine analogue-oligoarginine conjugates in protein kinase a and implications for protein substrate interactions.

Alexander Pflug1, Jevgenia Rogozina2, Darja Lavogina3, Erki Enkvist4, Asko Uri5, Richard Alan Engh6, Dirk Bossemeyer7.   

Abstract

Crystal structures of the catalytic subunit α of cAMP-dependent protein kinase (PKAc) with three adenosine analogue-oligoarginine conjugates (ARCs) are presented. The rationally designed ARCs include moieties that, in combination, target both the ATP- and the peptide-substrate-binding sites of PKAc, thereby taking advantage of high-affinity binding interactions offered by the ATP site while utilizing an additional mechanism for target specificity via binding to the peptide substrate site. The crystal structures demonstrate that, in accord with the previously reported bisubstrate character of ARCs, the inhibitors occupy both binding sites of PKAc. Further, they show new binding modes that may also apply to natural protein substrates of PKAc, which have not been revealed by previous crystallographic studies. The crystal structures described here contribute to the understanding of the substrate-binding patterns of PKAc and should also facilitate the design of inhibitors targeting PKAc and related protein kinases.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20732331     DOI: 10.1016/j.jmb.2010.08.028

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  5 in total

1.  Design and characterization of a potent and selective dual ATP- and substrate-competitive subnanomolar bidentate c-Jun N-terminal kinase (JNK) inhibitor.

Authors:  John L Stebbins; Surya K De; Petra Pavlickova; Vida Chen; Thomas Machleidt; Li-Hsing Chen; Christian Kuntzen; Shinichi Kitada; Michael Karin; Maurizio Pellecchia
Journal:  J Med Chem       Date:  2011-08-23       Impact factor: 7.446

2.  Conformational transition paths harbor structures useful for aiding drug discovery and understanding enzymatic mechanisms in protein kinases.

Authors:  Chung F Wong
Journal:  Protein Sci       Date:  2015-06-22       Impact factor: 6.725

3.  Co-crystal structures of the protein kinase haspin with bisubstrate inhibitors.

Authors:  Darja Lavogina; Katrin Kestav; Apirat Chaikuad; Christina Heroven; Stefan Knapp; Asko Uri
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2016-04-22       Impact factor: 1.056

4.  Rational drug-design approach supported with thermodynamic studies - a peptide leader for the efficient bi-substrate inhibitor of protein kinase CK2.

Authors:  Maria Winiewska-Szajewska; Dawid Płonka; Igor Zhukov; Jarosław Poznański
Journal:  Sci Rep       Date:  2019-07-29       Impact factor: 4.379

5.  Chemical Modification of Phage-Displayed Helix-Loop-Helix Peptides to Construct Kinase-Focused Libraries.

Authors:  Daisuke Fujiwara; Kousuke Mihara; Ryo Takayama; Yusuke Nakamura; Mitsuhiro Ueda; Takeshi Tsumuraya; Ikuo Fujii
Journal:  Chembiochem       Date:  2021-10-19       Impact factor: 3.461

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.